Profile data is unavailable for this security.
About the company
Jinyao Pharmaceutical Co Ltd, formerly Tianjin Tianyao Pharmaceuticals Co., Ltd., is a China-based company mainly engaged in the research and development, production and sales of corticosteroids and amino acid APIs and preparations. The Company's main products include dexamethasone series, prednisone series, methylprednisolone series, betamethasone series and more than 40 varieties of corticosteroid raw materials, 23 varieties of amino acid raw materials, and 16 dosage forms such as tablets, injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, and inhalation preparations. The Company mainly operates in the domestic market and overseas markets.
- Revenue in CNY (TTM)3.52bn
- Net income in CNY152.00m
- Incorporated1999
- Employees2.68k
- LocationJinyao Pharmaceutical Co LtdNo. 221, Huanghai Road, Development ZoneTIANJIN 300457ChinaCHN
- Phone+86 2 260740048
- Fax+86 2 265277561
- Websitehttp://www.tjpcty.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yabao Pharmaceutical Group Co Ltd | 2.83bn | 220.70m | 4.49bn | 4.14k | 20.41 | 1.52 | -- | 1.59 | 0.3057 | 0.3057 | 3.86 | 4.10 | 0.7389 | 3.51 | 6.66 | 683,686.80 | 5.11 | 2.82 | 6.38 | 3.97 | 52.85 | 59.20 | 6.92 | 4.19 | 2.04 | 129.51 | 0.0313 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
| Zhejiang Shouxiangu Pharmaceuticl Co Ltd | 713.75m | 233.79m | 4.51bn | 1.14k | 19.07 | 2.02 | -- | 6.32 | 1.19 | 1.19 | 3.63 | 11.26 | 0.2367 | 0.7194 | 7.25 | 624,455.80 | 7.75 | 10.04 | 9.09 | 11.63 | 80.01 | 83.66 | 32.75 | 28.29 | 3.48 | -- | 0.2098 | 47.86 | -5.39 | 8.93 | -8.39 | 18.78 | 12.23 | 17.13 |
| Lionco Pharmaceutical Group Co Ltd | 277.20m | -101.80m | 4.53bn | 475.00 | -- | 5.29 | -- | 16.34 | -0.144 | -0.144 | 0.3828 | 1.19 | 0.1843 | 2.48 | 4.41 | 583,571.30 | -6.77 | 0.7396 | -7.85 | 0.9562 | 41.77 | 80.88 | -36.73 | 2.08 | 4.94 | -4.74 | 0.2409 | 521.93 | -31.95 | -34.79 | 22.65 | -- | -33.18 | -- |
| Pulike Biological Engineering Inc | 1.09bn | 101.68m | 4.57bn | 1.68k | 44.67 | 1.71 | -- | 4.21 | 0.296 | 0.296 | 3.13 | 7.72 | 0.3373 | 2.48 | 2.65 | 646,748.50 | 3.16 | 7.64 | 3.73 | 8.96 | 60.45 | 62.57 | 9.36 | 17.85 | 2.51 | -- | 0.0086 | 52.48 | 1.84 | 15.55 | 3.99 | 5.17 | 41.58 | 18.47 |
| ZhuZhou QianJin Pharmaceutical Co., Ltd | 3.73bn | 291.57m | 4.62bn | 5.34k | 15.75 | 1.92 | -- | 1.24 | 0.6922 | 0.6922 | 8.84 | 5.69 | 0.835 | 3.88 | 10.04 | 699,947.80 | 8.25 | 8.99 | 15.12 | 16.21 | 45.06 | 44.59 | 9.88 | 10.03 | 2.18 | -- | 0.09 | 68.27 | -5.66 | 2.68 | 5.53 | 4.64 | -1.06 | -2.64 |
| Shanghai OPM Biosciences Co Ltd | 287.29m | 38.09m | 4.63bn | 285.00 | 121.22 | 2.20 | -- | 16.10 | 0.3324 | 0.3324 | 2.52 | 18.31 | 0.1259 | 2.23 | 3.59 | 1,008,039.00 | 1.63 | 4.34 | 1.69 | 4.65 | 57.28 | 58.31 | 12.93 | 23.40 | 17.02 | -- | 0.0311 | 45.38 | -17.41 | 48.34 | -48.72 | -- | 6.09 | -- |
| Jinyao Pharmaceutical Co Ltd | 3.52bn | 152.00m | 4.75bn | 2.68k | 31.23 | 1.55 | -- | 1.35 | 0.139 | 0.139 | 3.22 | 2.79 | 0.574 | 2.43 | 9.06 | 1,313,392.00 | 3.39 | 1.91 | 5.65 | 3.40 | 41.79 | 46.33 | 5.90 | 3.31 | 0.9536 | 14.68 | 0.189 | 44.40 | 2.55 | 9.28 | 230.60 | -4.22 | -9.58 | 9.21 |
| Jiangsu Jibeier Pharmaceutical Co Ltd | 887.17m | 238.58m | 4.86bn | 1.45k | 19.47 | 2.16 | -- | 5.48 | 1.25 | 1.25 | 4.64 | 11.31 | 0.3848 | 2.99 | 3.78 | 613,955.40 | 10.34 | 9.77 | 11.16 | 10.66 | 87.99 | 88.44 | 26.86 | 23.29 | 9.03 | -- | 0.0014 | 30.68 | 31.49 | 12.16 | 41.65 | 17.79 | 112.78 | -- |
Data as of Nov 06 2024. Currency figures normalised to Jinyao Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.58%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Broad Fund Management Co. Ltd.as of 30 Jun 2024 | 2.85m | 0.26% |
| The Vanguard Group, Inc.as of 02 Oct 2024 | 2.09m | 0.19% |
| Great Wall Fund Management Co., Ltd.as of 30 Jun 2024 | 460.60k | 0.04% |
| Bodao Fund Management Co Ltd.as of 30 Jun 2024 | 263.70k | 0.02% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 240.60k | 0.02% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2024 | 121.90k | 0.01% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2024 | 110.80k | 0.01% |
| Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 30 Jun 2024 | 75.20k | 0.01% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 50.30k | 0.01% |
| Everbright Securities Asset Management Co., Ltd.as of 30 Jun 2024 | 31.70k | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
